MDBriefCase will be unavailable due to maintenance from Sunday, January 14 11PM to Monday, January 15 1AM ET.
Welcome
Medications, along with hospital costs, constitute one of the major health spending categories in Canada, with at least 1 in 10 Canadian adults regularly taking prescriptions to treat high blood pressure, high blood cholesterol or mood disorders.
For years, when patients needed a new prescription or a refill on existing medication, they were required to make an appointment to see their doctor in person. However, when COVID-19 hit in 2020, lockdowns and closures forced a rapid shift to digital healthcare, with many in-person doctor appointments replaced by telemedicine or virtual visits — yet through it all, the need for prescription medications did not disappear.
With the shift to digital health here to stay — a recent report found that almost half of Canadians have now accessed a physician using virtual care, and 91 percent are satisfied with the service they received — the healthcare industry faces some important questions.
How can patients receive medication without picking up a prescription from their doctor?
How can pharmacists verify the authenticity of a prescription and dispense with confidence?
How can physicians know that the medication has been picked up, and no follow-up call with a patient is required?
A Canadian Digital Health Survey found that 80 percent of Canadians are interested in having their prescription sent directly to a pharmacy from their doctor’s office. Currently, there are two ways this can be done: via fax or via electronic prescribing (e-prescribing).
Fax machines are archaic, unreliable, error-prone, and often cause unnecessary delays in patient care due to malfunctions, illegible handwriting, or pharmacists requiring clarification on prescriptions.
Alternatively, an e-prescribing solution integrates into the pharmacy management system (PMS) of a pharmacy and electronic medical record (EMR) of a doctor to digitally transmit a prescription from a prescriber to a patient’s pharmacy of choice.
Once a prescription has been transmitted, it populates fields in the pharmacy management system, ensuring the name of the drug and dosage are clear. Pharmacy professionals do not have to manually input the information and worry about deciphering illegible handwriting — they can be certain that the prescription is authentic and came straight from a physician’s office. If there are any questions or clarifications required, pharmacists can use a clinical communications tool in the platform to message a physician. No more phone tag or unnecessary delays.
E-prescribing also helps physicians see whether or not the prescription has been picked up, providing important insight into their patient’s medication adherence. Physicians can also approve a prescription renewal request straight from their EMR. With 86 percent of physicians in Canada already using EMR systems, integrating e-prescribing solutions would be fairly simple and have a profound impact on healthcare delivery.
The service is also incredibly convenient for patients: for 1 in 3 Canadians, a virtual visit ends in a prescription renewal. With e-prescribing, patients no longer have to worry about lost prescriptions or taking time off to see their doctor for renewals. All they have to do is head to their pharmacy of choice and ask for their prescription.
The process is seamless, convenient, and safe. E-prescribing is emerging as a prevalent way to receive, create, or dispense prescriptions, steadily replacing other forms of provider-to-provider communication.
+ + +
Want to learn more about how e-prescribing can help your practice? MDBriefCase is free to join and offers a complimentary CME course on medication management with e-prescribing.
199 Bay Street #4000, Toronto,
ON M5L 1A9
In submitting your work (the “Work”) for potential posting on the MDBriefCase Healthcare Leadership Lab website (the “Website”), you (“You”) expressly agree to the following:
Review: MDBriefCase is pleased to consider the publication of Your Work on the Website. The suitability of the Work for posting shall be determined by MDBRiefCase at its sole discretion. Nothing herein shall obligate MDBriefcase to post or otherwise publish the Work, or the maintain its posting in future.
Editing; Identification: MDBriefcase shall have the right to edit the Work to conform to our standards of style, technological requirements, language usage, grammar and punctuation, provided that the meaning of the Work is not materially altered. If posted, You will be identified as the author of the Work, or co-author if applicable.
Grant of Rights: As a condition of publication and for no monetary compensation, You hereby grant to MDBriefCase the following rights to the Work in any and all media whether now existing or hereafter developed, including print and electronic/digital formats: (1) the exclusive right of first publication worldwide; (2) the perpetual non-exclusive worldwide right to publish, reproduce, distribute, sell, adapt, perform, display, sublicense, and create derivative works, alone or in conjunction with other materials; (3) the perpetual non-exclusive worldwide right to use the Work, or any part thereof, in any other publication produced by MDBriefCase and/or on MDBriefCase’s website; and (4) the perpetual non-exclusive worldwide right to use the Work to promote and publicize MDBriefCase or its publications. The grant of rights survives termination or expiration of this Agreement.
Warranty: You warrant that the Work is original with You and that it is not subject to any third party copyright; that You have authority to grant the rights in this Agreement; that publication of the Work will not libel anyone or infringe on or invade the rights of others; that You have full power and authority to enter into this Agreement; that the Work has not been published elsewhere in whole or in part; and that You have obtained permission from the copyright owner consistent with this Agreement for any third party copyrighted material in the Work. This warranty survives termination or expiration of this Agreement.
Thank you for your interest in writing an article for the MDBriefCase Healthcare Leadership Lab website.
The Healthcare Leadership Lab welcomes submissions on all topics relevant to leaders in healthcare. Our topics include Leading in Healthcare, Leadership Lessons from COVID-19 and others. We prioritize stories that provide leadership advice to executives and managers in healthcare companies, offer actionable strategies for executing successful projects, and provide interesting angles on current healthcare topics. Submissions must be original work of the authors and unpublished. When submitting, authors represent that they have included no material that is in violation of the rights of any other person or entity.
Articles must be educational and non-promotional. If they mention the author’s company or any of the company’s products or services by name within the text, such mention should be very limited and used for reference only, not for promotion. (For example, an author might cite a survey conducted by his company but not describe his company’s product as a solution to a business problem.) Articles will be edited for clarity, style and brevity. The final headline is determined by the editor.
Guest articles for the MDBriefCase Healthcare Leadership Lab may run between 500 and 1000 words.
MDBriefCase reserves the right to accept or reject any submission and the right to condition acceptance upon revision of material to conform to its criteria.
There is no payment for contributed articles. However, MDBriefCase will give the author a byline. Authors are invited to link to the article on personal websites, corporate websites and social media platforms.
Each author understands and agrees that any submission accepted for posting is provided subject to MDBriefCase’s Author Agreement.
